Cargando…
Venoms as an adjunctive therapy for Parkinson’s disease: where are we now and where are we going?
Neurodegenerative diseases, including Parkinson’s disease (PD), are increasing in the aging population. Crucially, neurodegeneration of dopaminergic neurons in PD is associated with chronic inflammation and glial activation. Besides this, bradykinesia, resting tremor, rigidity, sensory alteration, a...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787152/ https://www.ncbi.nlm.nih.gov/pubmed/33437512 http://dx.doi.org/10.2144/fsoa-2020-0119 |